United States · 
Who invested in Comanche Biopharma?
Comanche Biopharma's investors include New Enterprise Associates, Google Ventures, Atlas Venture and Lilly Asia Ventures.
United States · Series B startup
Who invested in Comanche Biopharma
Funding summaryUpdated 26 Oct 2026
$75Mraised across 1 round since 2024, from 1 source
- Latest round
- Series B, $75MJan 2024
- Investors
- 4
The rounds
- Jan 2024Series B$75M
Source recordedSEC filing: $38M sold, first sale Dec 2023
Founders and team
From Comanche Biopharma's own website and the SEC filings it signed: 1 founder, 9 on the team.
Mike YoungPresident & Co-Founder
- Michael FerencikGlobal Head of Design & IT
- Alexander WinchellDirector of Clinical Development Operations
- Andrea AbdulaDirector of Quality Compliance
- John McHutchisonMuz Mansuri, Chair
- Mack AylesworthQuality Management Systems Program Director
- Scott JohnsonMuz Mansuri, Chair
- Allison Scott AugustExecutive Officeri
- Michael Scott YoungExecutive Officeri
- Thomas Scott JohnsonExecutive Officer, Directori
On the board, as filediAllyson Scott FelixAnn Scott TaylorBrendan Scott Bulik-SullivanDavid Scott GrayzelKetan Scott PatelMuzammil Scott MansuriScott Scott Gottlieb
Everyone who backed them
Lilly Asia VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Comanche Biopharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Comanche Biopharma
How much has Comanche Biopharma raised?
Comanche Biopharma has raised $75M across 1 round since 2024.
When did Comanche Biopharma last raise?
Comanche Biopharma's most recent round was a Series B of $75M in Jan 2024.
What was Comanche Biopharma's biggest round?
Its most recent round, $75M in Jan 2024, is also its largest on record.
Who backed Comanche Biopharma first?
Comanche Biopharma's first round on record, in Jan 2024, was backed by New Enterprise Associates, Google Ventures and Atlas Venture and 1 others.
What stage is Comanche Biopharma at?
Comanche Biopharma's latest named round is a Series B, in Jan 2024.
Where is Comanche Biopharma based?
Comanche Biopharma is based in the United States.
Companies like Comanche Biopharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.